{
  "data": {
    "id": "stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF",
    "url": "https://statorigin.org/stat/stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF",
    "indicator": {
      "slug": "phase-iii-share-of-oncology-trials",
      "name": "Phase III share of oncology trials",
      "definition": "Share of oncology trials started that were Phase III."
    },
    "industry": [
      {
        "slug": "healthcare",
        "name": "Human health activities",
        "isic": "Q86",
        "is_primary": true
      }
    ],
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "period": {
      "start": "2024-01-01",
      "end": "2024-12-31",
      "type": "year"
    },
    "value": 14,
    "value_text": "14%",
    "unit": "percent",
    "currency": null,
    "scale": "1",
    "value_type": "actual",
    "source": {
      "org": "IQVIA Institute",
      "org_short_name": "IQVIA",
      "org_url": "https://www.iqvia.com",
      "org_tier": 3,
      "document_title": "Global Oncology Trends 2025",
      "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025",
      "document_type": "press_release",
      "locator": "Other Findings",
      "quote": "Phase II trials, including Phase I/II, IIa and IIb, represent the largest share of trials, with 48% of oncology trials started in 2024 being Phase II compared to 38% Phase I and 14% Phase III.",
      "published_date": null,
      "accessed_at": "2026-09-16",
      "license": "see-source",
      "url_status": "ok"
    },
    "verification": "verified",
    "verified_by": "seed:auto-extract-v1",
    "verified_at": "2026-09-17T01:20:11.850Z",
    "confidence": 0.9,
    "is_secondhand": false,
    "supersedes": null,
    "superseded_by": null,
    "is_current": true,
    "citation": {
      "apa": "IQVIA Institute. (2024). Global Oncology Trends 2025. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Via StatOrigin, https://statorigin.org/stat/stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF",
      "bibtex": "@misc{iqvia2024phasedyeysf,\n  author       = {{IQVIA Institute}},\n  title        = {Global Oncology Trends 2025},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF},\n  note         = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed September 16, 2026.}\n}"
    },
    "updated_at": "2026-09-17T01:20:11.850Z",
    "contested_by": [],
    "related": []
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}